GCGM
General Catalyst Group Management’s ArriVent BioPharma AVBP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.5M | Hold |
1,494,786
| – | – | 0.76% | 5 |
|
|
2025
Q1 | $27.6M | Hold |
1,494,786
| – | – | 3.11% | 6 |
|
|
2024
Q4 | $39.8M | Hold |
1,494,786
| – | – | 3.49% | 6 |
|
|
2024
Q3 | $35.1M | Hold |
1,494,786
| – | – | 2.45% | 6 |
|
|
2024
Q2 | $27.7M | Hold |
1,494,786
| – | – | 2.39% | 5 |
|
|
2024
Q1 | $26.7M | Buy |
+1,494,786
| New | +$26.7M | 2.05% | 7 |
|